sage-217
Showing 1 - 10 of 10
MDD Trial (SAGE-217)
Not yet recruiting
- Major Depressive Disorder
- SAGE-217
- (no location specified)
Dec 9, 2022
MDD, Insomnia Trial in United States (SAGE-217, Placebo)
Terminated
- Major Depressive Disorder
- Insomnia
- SAGE-217
- Placebo
-
Little Rock, Arkansas
- +27 more
Oct 13, 2022
Bipolar Disorder I, Bipolar Disorder II, Major Depressive Episode Trial in United States (SAGE-217, Placebo)
Completed
- Bipolar Disorder I
- +2 more
- SAGE-217
- Placebo
-
Little Rock, Arkansas
- +10 more
Mar 23, 2022
Parkinson Disease Trial in United States (SAGE-217, Levodopa, Antiparkinsonian Agent(s))
Completed
- Parkinson Disease
- SAGE-217
- +2 more
-
Panorama City, California
- +10 more
Jan 20, 2022
MDD Trial in United States (SAGE-217, Placebo)
Completed
- Major Depressive Disorder
- SAGE-217
- Placebo
-
Rogers, Arkansas
- +52 more
Nov 22, 2022
Major Depression Trial in United States (SAGE-217, Placebo)
Completed
- Major Depression
- SAGE-217
- Placebo
-
Garden Grove, California
- +7 more
Jan 20, 2022
Depressive Disorder, Major Trial in United States (SAGE-217, Placebo)
Completed
- Depressive Disorder, Major
- SAGE-217
- Placebo
-
Rogers, Arkansas
- +37 more
Mar 25, 2022
Depressive Disorder, Major Trial in United States (SAGE-217, Matching Placebo, Sertraline)
Completed
- Depressive Disorder, Major
- SAGE-217
- +6 more
-
Dothan, Alabama
- +50 more
Feb 28, 2022
MDD Trial in United States (SAGE-217, Placebo)
Terminated
- Major Depressive Disorder
- SAGE-217
- Placebo
-
Bentonville, Arkansas
- +45 more
Oct 15, 2021